455 related articles for article (PubMed ID: 8265649)
1. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6.
Tamura T; Udagawa N; Takahashi N; Miyaura C; Tanaka S; Yamada Y; Koishihara Y; Ohsugi Y; Kumaki K; Taga T
Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11924-8. PubMed ID: 8265649
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation.
Kotake S; Sato K; Kim KJ; Takahashi N; Udagawa N; Nakamura I; Yamaguchi A; Kishimoto T; Suda T; Kashiwazaki S
J Bone Miner Res; 1996 Jan; 11(1):88-95. PubMed ID: 8770701
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional induction of cyclooxygenase-2 in osteoblasts is involved in interleukin-6-induced osteoclast formation.
Tai H; Miyaura C; Pilbeam CC; Tamura T; Ohsugi Y; Koishihara Y; Kubodera N; Kawaguchi H; Raisz LG; Suda T
Endocrinology; 1997 Jun; 138(6):2372-9. PubMed ID: 9165025
[TBL] [Abstract][Full Text] [Related]
4. The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures.
Romas E; Udagawa N; Zhou H; Tamura T; Saito M; Taga T; Hilton DJ; Suda T; Ng KW; Martin TJ
J Exp Med; 1996 Jun; 183(6):2581-91. PubMed ID: 8676079
[TBL] [Abstract][Full Text] [Related]
5. Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors.
Udagawa N; Takahashi N; Katagiri T; Tamura T; Wada S; Findlay DM; Martin TJ; Hirota H; Taga T; Kishimoto T; Suda T
J Exp Med; 1995 Nov; 182(5):1461-8. PubMed ID: 7595216
[TBL] [Abstract][Full Text] [Related]
6. Expression of IL-6 receptor and GP130 in mouse bone marrow cells during osteoclast differentiation.
Gao Y; Morita I; Maruo N; Kubota T; Murota S; Aso T
Bone; 1998 May; 22(5):487-93. PubMed ID: 9600782
[TBL] [Abstract][Full Text] [Related]
7. Coadministration of interleukin-6 (IL-6) and soluble IL-6 receptor delays progression of wobbler mouse motor neuron disease.
Ikeda K; Kinoshita M; Tagaya N; Shiojima T; Taga T; Yasukawa K; Suzuki H; Okano A
Brain Res; 1996 Jul; 726(1-2):91-7. PubMed ID: 8836549
[TBL] [Abstract][Full Text] [Related]
8. gp130 and c-Kit signalings synergize for ex vivo expansion of human primitive hemopoietic progenitor cells.
Sui X; Tsuji K; Tanaka R; Tajima S; Muraoka K; Ebihara Y; Ikebuchi K; Yasukawa K; Taga T; Kishimoto T
Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2859-63. PubMed ID: 7535932
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of interleukin-4 on osteoclast-like cell formation in mouse bone marrow culture.
Kasono K; Sato K; Sato Y; Tsushima T; Shizume K; Demura H
Bone Miner; 1993 Jun; 21(3):179-88. PubMed ID: 8400918
[TBL] [Abstract][Full Text] [Related]
10. Chinese hamster ovary cells expressing alpha4beta1 integrin stimulate osteoclast formation in vitro.
Akatsu T; Ono K; Murakami T; Katayama Y; Nishikawa M; Wada S; Yamamoto M; Kugai N; Matsuura N; Takada Y; Nagata N
J Bone Miner Res; 1998 Aug; 13(8):1251-9. PubMed ID: 9718193
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 and soluble interleukin-6 receptor suppress osteoclastic differentiation by inducing PGE(2) production in chondrocytes.
Honda K
J Oral Sci; 2011 Mar; 53(1):87-96. PubMed ID: 21467819
[TBL] [Abstract][Full Text] [Related]
12. The soluble form of the IL-6 receptor (sIL-6R alpha) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells; the soluble form of gp130 is antagonistic for sIL-6R alpha-induced AIDS-KS cell growth.
Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
Int Immunol; 1996 Apr; 8(4):595-602. PubMed ID: 8722639
[TBL] [Abstract][Full Text] [Related]
13. Interaction of triiodothyronine with 1alpha,25-dihydroxyvitamin D3 on interleukin-6-dependent osteoclast-like cell formation in mouse bone marrow cell cultures.
Schiller C; Gruber R; Ho GM; Redlich K; Gober HJ; Katzgraber F; Willheim M; Hoffmann O; Pietschmann P; Peterlik M
Bone; 1998 Apr; 22(4):341-6. PubMed ID: 9556133
[TBL] [Abstract][Full Text] [Related]
14. Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function.
Hill PA; Reynolds JJ; Meikle MC
Endocrinology; 1995 Jan; 136(1):124-31. PubMed ID: 7828521
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of osteoclast differentiation in vitro by mouse oncostatin M, leukaemia inhibitory factor, cardiotrophin-1 and interleukin 6: synergy with dexamethasone.
Richards CD; Langdon C; Deschamps P; Pennica D; Shaughnessy SG
Cytokine; 2000 Jun; 12(6):613-21. PubMed ID: 10843736
[TBL] [Abstract][Full Text] [Related]
16. Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family.
Mihara M; Kasutani K; Okazaki M; Nakamura A; Kawai S; Sugimoto M; Matsumoto Y; Ohsugi Y
Int Immunopharmacol; 2005 Nov; 5(12):1731-40. PubMed ID: 16102523
[TBL] [Abstract][Full Text] [Related]
17. Gp130 activation by soluble interleukin-6 receptor/interleukin-6 enhances osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells.
Erices A; Conget P; Rojas C; Minguell JJ
Exp Cell Res; 2002 Oct; 280(1):24-32. PubMed ID: 12372336
[TBL] [Abstract][Full Text] [Related]
18. Characterization of anti-mouse interleukin-6 receptor antibody.
Okazaki M; Yamada Y; Nishimoto N; Yoshizaki K; Mihara M
Immunol Lett; 2002 Dec; 84(3):231-40. PubMed ID: 12413742
[TBL] [Abstract][Full Text] [Related]
19. Intercellular adhesion molecule-1 on synovial cells attenuated interleukin-6-induced inhibition of osteoclastogenesis induced by receptor activator for nuclear factor κB ligand.
Suzuki M; Hashizume M; Yoshida H; Shiina M; Mihara M
Clin Exp Immunol; 2011 Jan; 163(1):88-95. PubMed ID: 21039424
[TBL] [Abstract][Full Text] [Related]
20. Synergy between IL-6 and soluble IL-6 receptor enhances bone morphogenetic protein-2/absorbable collagen sponge-induced bone regeneration via regulation of BMPRIA distribution and degradation.
Huang RL; Chen G; Wang W; Herller T; Xie Y; Gu B; Li Q
Biomaterials; 2015 Oct; 67():308-22. PubMed ID: 26232880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
